GlassScriptPhysician profile
Marco Palmieri
NPI 1649447335
$4,792.45
in general payments reported to CMS, 2019-2025
11 companies · $943 in 2025
The $943 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,397 · 2020: $16.92 · 2021: $565 · 2022: $521 · 2023: $548 · 2024: $801 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,291.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,208.43 | 2024-2025 | Intracept |
| Saluda Medical Americas, INC. | $859.51 | 2022-2025 | Evoke, Evoke Scs |
| Relievant Medsystems, INC. | $805.19 | 2020-2023 | Intracept |
| Medtronic USA, INC. | $569.87 | 2019 | |
| Abbott Laboratories | $501.14 | 2019-2024 | Proclaim |
| Medtronic, INC. | $299.31 | 2021-2024 | Intellis Adaptivestim |
| Nevro Corp. | $280.85 | 2019 | |
| Spr Therapeutics, INC | $102.58 | 2025 | Sprint Pns System |
| Curonix LLC | $102.06 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $50.00 | 2019 | |
| Pfizer INC. | $13.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Palmieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.